Sharda Cropchem quarterly results

Q1 FY27 · Apr–Jun 2026

₹ crore	Q1 FY27	Q1 FY26	Change
Revenue	1,074	985	+9.0%
EBITDA	186	215	−13.6%
EBITDA margin	17.3%	21.9%	−4.5 pts
Profit before tax	118	169	−30.0%
Net profit	88.0	143	−38.4%
EPS	₹9.76	₹15.83	−38.3%

Every quarter

₹ crore except per share

Tap a line for its trend	Q1 FY27Jun 2026	Q4 FY26Mar 2026	Q3 FY26Dec 2025	Q2 FY26Sep 2025	Q1 FY26Jun 2025	Q4 FY25Mar 2025	Q3 FY25Dec 2024	Q2 FY25Sep 2024	Q1 FY25Jun 2024	Q4 FY24Mar 2024	Q3 FY24Dec 2023	Q2 FY24Sep 2023	Earlier quartersAlpha Plus

Expenses
	1,074	2,065	1,289	929	985	1,829	929	777	785	1,312	632	581	Earlier quartersEvery year the company has filed comes with Alpha Plus.
	34.5	22.4	21.2	29.4	32.5	25.2	0.6	25.5	19.3	−2.0	12.2	23.6
	1,108	2,087	1,310	958	1,017	1,854	930	802	804	1,310	645	604
	374	915	548	376	391	828	318	295	336	603	279	273
	476	73.1	434	424	315	304	573	300	135	209	266	188
	−170	307	−143	−192	−70.3	152	−265	−32.1	85.7	46.3	−78.6	−25.0
	17.7	23.0	16.5	12.3	14.9	18.2	12.3	10.4	11.2	14.7	9.4	9.2
	1.8	0.5	0.4	0.3	0.6	0.4	0.5	0.5	0.8	0.2	0.9	4.6
	100	87.0	83.3	76.2	78.1	71.9	68.9	69.1	64.8	54.3	68.6	74.0
	190	260	193	176	119	223	177	115	141	184	86.8	115
	990	1,665	1,131	873	848	1,598	884	757	774	1,112	633	638
	186	487	241	133	215	303	115	89.6	77.0	255	69.5	21.2
	85.7	400	158	56.7	137	231	45.8	20.5	12.3	201	0.9	−52.8
Profit
	118	422	179	85.7	169	256	45.9	45.5	30.8	198	12.1	−33.8
	118	422	179	85.7	169	256	45.9	45.5	30.8	198	12.1	−33.8
	31.7	67.8	22.5	10.5	33.3	30.5	14.6	2.6	5.6	29.7	1.7	1.1
	−1.3	35.5	11.0	0.8	−7.0	22.0	0.2	0.5	−2.1	25.2	5.8	−7.4
	30.4	103	33.4	11.4	26.3	52.5	14.8	3.1	3.5	54.9	7.5	−6.3
	88.0	319	145	74.4	143	204	31.1	42.4	27.3	143	4.6	−27.6
	88.0	319	145	74.4	143	204	31.1	42.4	27.3	143	4.6	−27.6
	19.8	42.0	9.4	6.9	5.0	9.2	−8.8	7.6	6.4	−3.5	3.8	−5.8
	108	361	155	81.3	148	213	22.3	50.0	33.7	140	8.4	−33.4
	88.0	319	145	74.3	143	204	31.1	42.4	27.3	143	4.6	−27.6
	−0.0	0.1	−0.0	0.0	0.0	0.0	−0.0	0.0	−0.0	0.0	0.0	0.0
Per share
	₹9.76	₹35.32	₹16.09	₹8.24	₹15.83	₹22.57	₹3.45	₹4.70	₹3.02	₹15.90	₹0.51	−₹3.06
	₹9.76	₹35.32	₹16.09	₹8.24	₹15.83	₹22.57	₹3.45	₹4.70	₹3.02	₹15.90	₹0.51	−₹3.06
Other comprehensive income — detail
	19.8	42.0	9.4	6.9	5.0	9.2	—	—	—	—	—	—
	−0.0	−0.1	0.1	−0.1	0.0	0.2	−0.0	−0.0	−0.0	−0.2	0.0	0.0
	−0.0	−0.0	0.0	−0.0	0.0	0.0	—	—	—	—	—	—
	—	—	—	—	—	—	−0.0	−0.0	−0.0	−0.0	0.0	0.0
	19.8	42.0	9.3	7.0	5.0	9.0	−8.8	7.6	6.5	−3.4	3.8	−5.8
	108	361	155	81.2	148	213	22.3	50.0	33.7	140	8.4	−33.4
	−0.0	0.1	−0.0	0.0	0.0	0.0	−0.0	0.0	−0.0	0.0	0.0	0.0
Per share — as-filed variants
	₹9.76	₹35.32	₹16.09	₹8.24	₹15.83	₹22.57	₹3.45	₹4.70	₹3.02	₹15.90	₹0.51	−₹3.06
	₹9.76	₹35.32	₹16.09	₹8.24	₹15.83	₹22.57	₹3.45	₹4.70	₹3.02	₹15.90	₹0.51	−₹3.06
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	394	770	450	321	349	544	304	215	229	454	166	146
	36.7%	37.3%	34.9%	34.5%	35.5%	29.8%	32.7%	27.6%	29.2%	34.6%	26.2%	25.1%
Adjusted (ex-exceptional items) — derived
	118	422	179	85.7	169	256	45.9	45.5	30.8	198	12.1	−33.8
	88.0	319	145	74.4	143	204	31.1	42.4	27.3	143	4.6	−27.6
	₹9.76	₹35.32	₹16.09	₹8.24	₹15.83	₹22.57	₹3.45	₹4.70	₹3.02	₹15.90	₹0.51	−₹3.06

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

SHARDACROP₹682.30

Sharda Cropchem Ltd.

· Chemicals

Annual Quarterly₹ CrorePeersUPL PIIND STYRENIX REFEX SUDARSCHEM SUDEEPPHRM RCF RALLISMcap ₹6,156 Cr

View

In ₹ Crore except Per Share 3 Months Ending	Q2 FY24 30/09/2023	Q3 FY24 31/12/2023	Q4 FY24 31/03/2024	Q1 FY25 30/06/2024	Q2 FY25 30/09/2024	Q3 FY25 31/12/2024	Q4 FY25 31/03/2025	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026
Revenue from Operations	580.8	632.5	1,312.1	785.1	776.9	929.3	1,828.5	984.8	929.1	1,288.8	2,064.9	1,073.8
Other Income	23.6	12.2	-2.0	19.3	25.5	0.6	25.2	32.5	29.4	21.2	22.4	34.5
Total Income	604.3	644.6	1,310.0	804.4	802.4	929.9	1,853.8	1,017.3	958.5	1,310.0	2,087.3	1,108.3
Expenses
+ Cost of Materials Consumed	272.6	279.2	603.0	335.7	294.6	317.9	828.2	390.6	376.2	547.6	914.5	373.5
+ Purchases of Stock-in-Trade	187.6	266.2	208.9	134.9	299.7	572.6	304.1	315.3	423.9	433.7	73.1	476.4
+ Changes in Inventories	-25.0	-78.6	46.3	85.7	-32.1	-265.4	152.2	-70.3	-191.7	-142.8	307.1	-170.2
+ Employee Benefit Expense	9.2	9.4	14.7	11.2	10.4	12.3	18.2	14.9	12.3	16.5	23.0	17.7
+ Finance Costs	4.6	0.9	0.2	0.8	0.5	0.5	0.4	0.6	0.3	0.4	0.5	1.8
+ Depreciation & Amortisation	74.0	68.6	54.3	64.8	69.1	68.9	71.9	78.1	76.2	83.3	87.0	100.3
+ Other Expenses	115.1	86.8	184.3	140.7	114.7	177.3	222.6	119.0	175.5	192.8	260.1	190.4
Total Expenses	638.2	632.5	1,111.6	773.6	756.9	884.0	1,597.7	848.2	872.8	1,131.4	1,665.3	989.9
EBITDA	21.2	69.5	254.8	77.0	89.6	114.7	303.2	215.3	132.9	241.0	487.1	186.0
EBIT	-52.8	0.9	200.6	12.3	20.5	45.8	231.3	137.2	56.7	157.7	400.1	85.7
Profit
PBT before Exceptional Items	-33.8	12.1	198.4	30.8	45.5	45.9	256.1	169.1	85.7	178.6	422.1	118.4
Pretax Income	-33.8	12.1	198.4	30.8	45.5	45.9	256.1	169.1	85.7	178.6	422.1	118.4
+ Current Tax	1.1	1.7	29.7	5.6	2.6	14.6	30.5	33.3	10.5	22.5	67.8	31.7
+ Deferred Tax	-7.4	5.8	25.2	-2.1	0.5	0.2	22.0	-7.0	0.8	11.0	35.5	-1.3
Tax Expense	-6.3	7.5	54.9	3.5	3.1	14.8	52.5	26.3	11.4	33.4	103.4	30.4
Net Income	-27.6	4.6	143.5	27.3	42.4	31.1	203.6	142.8	74.4	145.1	318.7	88.0
+ Net Income — Continuing Ops	-27.6	4.6	143.5	27.3	42.4	31.1	203.6	142.8	74.4	145.1	318.7	88.0
+ Other Comprehensive Income	-5.8	3.8	-3.5	6.4	7.6	-8.8	9.2	5.0	6.9	9.4	42.0	19.8
Total Comprehensive Income	-33.4	8.4	140.0	33.7	50.0	22.3	212.8	147.8	81.3	154.5	360.7	107.8
Net Income to Common	-27.6	4.6	143.5	27.3	42.4	31.1	203.6	142.8	74.3	145.1	318.6	88.0
Minority Interest	0.0	0.0	0.0	-0.0	0.0	-0.0	0.0	0.0	0.0	-0.0	0.1	-0.0
Per Share
Basic EPS	-3.06	0.51	15.90	3.02	4.70	3.45	22.57	15.83	8.24	16.09	35.32	9.76
Diluted EPS	-3.06	0.51	15.90	3.02	4.70	3.45	22.57	15.83	8.24	16.09	35.32	9.76
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	—	—	—	—	9.2	5.0	6.9	9.4	42.0	19.8
+ Items NOT to be Reclassified to P&L	0.0	0.0	-0.2	-0.0	-0.0	-0.0	0.2	0.0	-0.1	0.1	-0.1	-0.0
+ Tax on Items NOT to be Reclassified	—	—	—	—	—	—	0.0	0.0	-0.0	0.0	-0.0	-0.0
+ Tax on Items NOT to be Reclassified — alt tag	0.0	0.0	-0.0	-0.0	-0.0	-0.0	—	—	—	—	—	—
+ Items to be Reclassified to P&L	-5.8	3.8	-3.4	6.5	7.6	-8.8	9.0	5.0	7.0	9.3	42.0	19.8
Comprehensive Income — Owners of Parent	-33.4	8.4	140.0	33.7	50.0	22.3	212.7	147.8	81.2	154.5	360.6	107.8
Comprehensive Income — Non-controlling Interests	0.0	0.0	0.0	-0.0	0.0	-0.0	0.0	0.0	0.0	-0.0	0.1	-0.0
Per Share — as-filed variants
Basic EPS — Continuing Operations	-3.06	0.51	15.90	3.02	4.70	3.45	22.57	15.83	8.24	16.09	35.32	9.76
Diluted EPS — Continuing Operations	-3.06	0.51	15.90	3.02	4.70	3.45	22.57	15.83	8.24	16.09	35.32	9.76
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	145.5	165.6	453.8	228.9	214.7	304.2	544.0	349.2	320.7	450.3	770.2	394.0
Gross Margin %	25.06	26.18	34.59	29.15	27.63	32.73	29.75	35.46	34.52	34.94	37.30	36.69
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	-33.8	12.1	198.4	30.8	45.5	45.9	256.1	169.1	85.7	178.6	422.1	118.4
Net Income Adj (tax-effected)	-27.6	4.6	143.5	27.3	42.4	31.1	203.6	142.8	74.4	145.1	318.7	88.0
EPS Adj	-3.06	0.51	15.90	3.02	4.70	3.45	22.57	15.83	8.24	16.09	35.32	9.76
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00
Paid Up Equity Capital	—	90.2	90.2	90.2	90.2	90.2	90.2	90.2	90.2	90.2	90.2	90.2

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Sharda Cropchem Q2 FY27 results date

Sharda Cropchem (NSE: SHARDACROP) will announce its Q2 FY27 results (July–September 2026) on Friday, 30 October 2026, according to the board-meeting notice it filed on 22 October 2026. Its latest results are for Q1 FY27 (April–June 2026). Consolidated net profit was ₹88 crore, down 38.3% from ₹143 crore in Q1 FY26 and down 72.4% from ₹319 crore in Q4 FY26. Revenue from operations was ₹1,074 crore, up 9.0% year on year and down 48.0% from the previous quarter.

Board-meeting notice filed: 22 October 2026
Q2 FY26 results (a year earlier): 30 October 2025
Q1 FY27 results (the latest): 29 July 2026

Latest results: Q1 FY27 (Apr–Jun 2026) · consolidated

Q2 FY27 results date: 30 October 2026Friday · notice filed 22 Oct
Q1 FY27 net profit: ₹88 Cr−38.3% vs Q1 FY26−72.4% vs Q4 FY26
Q1 FY27 revenue: ₹1,074 Cr+9.0% vs Q1 FY26−48.0% vs Q4 FY26
Q1 FY27 operating margin: 8.0%−6.0 pts vs Q1 FY26−11.4 pts vs Q4 FY26
Q2 FY26 net profit (a year earlier): ₹74.3 CrRevenue ₹929 Cr
Q1 FY27 EPS (basic): ₹9.76

Questions

When will Sharda Cropchem announce its Q2 FY27 results?

On 30 October 2026, the date of the board meeting called to approve them (notice filed with the exchanges on 22 October 2026). Last year it reported Q2 FY26 on 30 October 2025.

What will Sharda Cropchem's Q2 FY27 results be compared with?

With the same quarter a year earlier, Q2 FY26 (July–September 2025), when consolidated net profit was ₹74.3 crore and revenue from operations ₹929 crore. The latest quarter, Q1 FY27, had a net profit of ₹88 crore and revenue of ₹1,074 crore.

What were Sharda Cropchem's Q1 FY27 results?

Consolidated net profit was ₹88 crore, down 38.3% from ₹143 crore in Q1 FY26 and down 72.4% from ₹319 crore in Q4 FY26. Revenue from operations was ₹1,074 crore, up 9.0% year on year and down 48.0% from the previous quarter.

How has Sharda Cropchem's profit changed over the last four quarters?

Net profit by quarter: ₹74.3 crore in Q2 FY26, ₹145 crore in Q3 FY26, ₹319 crore in Q4 FY26 and ₹88 crore in Q1 FY27. That is ₹626 crore over the four quarters, up 49.1% from ₹420 crore in the four quarters before. Revenue from operations: ₹929 crore, ₹1,289 crore, ₹2,065 crore and ₹1,074 crore.

What was Sharda Cropchem's net profit in FY26?

Consolidated net profit was ₹681 crore in FY26 (April 2025–March 2026), up 123.7% from ₹304 crore in FY25. It was ₹31.9 crore in FY24 and ₹342 crore in FY23: up 99.1% over three years, 25.8% a year on average.

What was Sharda Cropchem's revenue in FY26?

Revenue from operations was ₹5,268 crore in FY26 (April 2025–March 2026), up 21.9% from ₹4,320 crore in FY25. It was ₹3,163 crore in FY24 and ₹4,045 crore in FY23: up 30.2% over three years, 9.2% a year on average.

Where do these Sharda Cropchem figures come from?

From Sharda Cropchem's own consolidated results filings to NSE, in ₹ crore as filed; the date from its board-meeting notices.

Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.